Print

BioNovo, Inc. (BNVI) to Host Conference Call to Discuss 2011 Highlights and Year-End Financial Results  
2/16/2012 9:55:37 AM

EMERYVILLE, Calif., Feb.16, 2012 /PRNewswire/ -- Bionovo, Inc. (OTC Link Platform: BNVI.PK) a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that it will host a conference call on Tuesday, February 21, 2012 at 1:30 PM PST to discuss its 2011 financial highlights for the year ended December 31, 2011.

(Logo: http://photos.prnewswire.com/prnh/20111110/SF04662LOGO)

Interested parties can access the call by dialing 877-941-8416, or listen via a live audio only webcast, which can be found at http://bionovo.com/investors/events. A replay of the call will be available by dialing 1-877-870-5176 (replay code: 4515311) through February 28, 2012 and archived via audio webcast at http://bionovo.com/investors/events.

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources, which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes it has discovered new classes of drug candidates within its rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and its stock is traded on the OTC Link Platform under the symbol "BNVI.PK." For more information about Bionovo and its programs, visit http://www.bionovo.com.

SOURCE Bionovo, Inc.


//-->